Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab + Methotrexate in Very Early Rheumatoid Arthritis (TOVERA)
NCT02837146Phase 3Unknown
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA). Status: unknown.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02837146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837146.